L8B Stock Overview
A medical device company, develops, produces, imports, distributes, and trades in cardiovascular related medical devices in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for L8B from our risk checks.
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Japan Lifeline Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥8.64 |
| 52 Week High | JP¥9.93 |
| 52 Week Low | JP¥8.37 |
| Beta | 0.22 |
| 1 Month Change | -7.61% |
| 3 Month Change | -9.58% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -12.99% |
Recent News & Updates
Recent updates
Shareholder Returns
| L8B | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 1.8% | -5.6% | -0.9% |
| 1Y | n/a | -14.7% | 14.1% |
Return vs Industry: Insufficient data to determine how L8B performed against the German Medical Equipment industry.
Return vs Market: Insufficient data to determine how L8B performed against the German Market.
Price Volatility
| L8B volatility | |
|---|---|
| L8B Average Weekly Movement | 4.6% |
| Medical Equipment Industry Average Movement | 6.6% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in DE Market | 12.7% |
| 10% least volatile stocks in DE Market | 3.1% |
Stable Share Price: L8B has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: Insufficient data to determine L8B's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 1,216 | Keisuke Suzuki | www.japanlifeline.com |
Japan Lifeline Co., Ltd., a medical device company, develops, produces, imports, distributes, and trades in cardiovascular related medical devices in Japan. The company’s cardiac rhythm management products include cardiac pacemakers, implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support devices; and electrophysiology/ablation products comprise electrophysiological and ablation catheters, irrigated tip ablation catheters, endoscopic balloon ablation systems, esophageal temperature monitoring systems, internal atrial cardioversion systems, and radio-frequency transseptal needles. Its cardiovascular and endografting products consist of vascular and open stent grafts, and abdominal stent-grafts, as well as embolic coil deploying systems; and coronary and peripheral intervention products include PTCA and PTA guide wires, and PTCA balloon catheters.
Japan Lifeline Co., Ltd. Fundamentals Summary
| L8B fundamental statistics | |
|---|---|
| Market cap | €625.71m |
| Earnings (TTM) | €57.55m |
| Revenue (TTM) | €349.70m |
Is L8B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| L8B income statement (TTM) | |
|---|---|
| Revenue | JP¥56.61b |
| Cost of Revenue | JP¥22.42b |
| Gross Profit | JP¥34.19b |
| Other Expenses | JP¥24.87b |
| Earnings | JP¥9.32b |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 132.92 |
| Gross Margin | 60.40% |
| Net Profit Margin | 16.46% |
| Debt/Equity Ratio | 6.0% |
How did L8B perform over the long term?
See historical performance and comparisonDividends
Does L8B pay a reliable dividends?
See L8B dividend history and benchmarks| Japan Lifeline dividend dates | |
|---|---|
| Ex Dividend Date | Mar 28 2025 |
| Dividend Pay Date | Jun 27 2025 |
| Days until Ex dividend | 57 days |
| Days until Dividend pay date | 34 days |
Does L8B pay a reliable dividends?
See L8B dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/23 10:54 |
| End of Day Share Price | 2025/05/23 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Japan Lifeline Co., Ltd. is covered by 9 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yang Luo | CLSA |
| null null | Company Forecast |
| Tomoko Yoshihara | Daiwa Securities Co. Ltd. |